Intercept Pharmaceuticals to Present at J.P. Morgan 41st Annual Healthcare Conference on January 12, 2023

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) announced that CEO Jerry Durso will present at the J.P. Morgan 41st Annual Healthcare Conference on January 12, 2023, at 12:00 p.m. PT. The presentation will focus on the company's innovative therapeutics for non-viral liver diseases. A live audio webcast of the event will be available and later archived on Intercept's investor webpage for four weeks. Intercept specializes in developing treatments for conditions such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).

MORRISTOWN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer, will give a corporate presentation at the J.P. Morgan 41^st Annual Healthcare Conference. Intercept’s presentation is scheduled for Thursday, January 12, at 12:00 p.m. Pacific Time.

A live audio webcast of the event can be found here. The webcast will also be available on the investor page of Intercept’s website as an audio archive for approximately four weeks following the presentation.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.

Contact
For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com

FAQ

When is Intercept Pharmaceuticals' presentation at the J.P. Morgan Healthcare Conference?

Intercept Pharmaceuticals' presentation is scheduled for January 12, 2023, at 12:00 p.m. Pacific Time.

Who is presenting for Intercept Pharmaceuticals at the conference?

CEO Jerry Durso will present for Intercept Pharmaceuticals.

Where can I find the webcast of Intercept Pharmaceuticals' presentation?

The webcast will be available on Intercept's investor page and can be accessed live and archived for four weeks.

What is the focus of Intercept Pharmaceuticals' presentation?

The presentation will focus on the company's novel therapeutics for treating progressive non-viral liver diseases.

What diseases does Intercept Pharmaceuticals target?

Intercept specializes in treatments for primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), and severe alcohol-associated hepatitis.